WallStreetZenWallStreetZen

NYSE: USNA
Usana Health Sciences Inc Stock Forecast, Predictions & Price Target

Analyst price target for USNA

Based on 2 analysts offering 12 month price targets for Usana Health Sciences Inc.
Min Forecast
$52.50-14.44%
Avg Forecast
$52.75-14.03%
Max Forecast
$53.00-13.62%

Should I buy or sell USNA stock?

Based on 2 analysts offering ratings for Usana Health Sciences Inc.
Sell
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
1 analysts 50%
Sell
1 analysts 50%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their USNA stock forecasts and price targets.

USNA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
DA Davidson
Top 18%
83
HoldMaintains$52.50-14.44%2023-02-13
Jefferies
Top 23%
78
SellDowngrades$53.00-13.62%2022-07-07

1 of 1

Forecast return on equity

Is USNA forecast to generate an efficient return?
Company
N/A
Industry
47.53%
Market
52.51%

Forecast return on assets

Is USNA forecast to generate an efficient return on assets?
Company
N/A
Industry
13.2%

USNA earnings per share forecast

What is USNA's earnings per share in the next 1 years based on estimates from 2 analysts?
Avg 1 year Forecast
$4.32+20%
USNA's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

USNA revenue forecast

What is USNA's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$1.0B+4.23%
Avg 2 year Forecast
$1.1B+13.26%
Avg 3 year Forecast
$1.1B+12.13%
USNA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

USNA earnings growth forecast

How is USNA forecast to perform vs Household & Personal Products companies and vs the US market?
Company
18.32%
Industry
9.57%
Market
26.86%
USNA's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
USNA's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
USNA's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

USNA revenue growth forecast

How is USNA forecast to perform vs Household & Personal Products companies and vs the US market?
Company
4.82%
Industry
3.01%
Market
9.33%
USNA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
USNA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

USNA vs Household & Personal Product Stocks

TickerPricePrice TargetUp/downsideConsensus
USNA$61.36$52.75-14.03%Sell
EWCZ$16.85$19.40+15.13%Buy
WALD$8.05$12.63+56.83%Strong Buy
SKIN$12.11$20.86+72.23%Strong Buy
NUS$38.94$39.33+1.01%Hold

Usana Health Sciences Stock Forecast FAQ

Is Usana Health Sciences Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NYSE: USNA) stock is to Sell USNA stock.

Out of 2 analysts, 0 (0%) are recommending USNA as a Strong Buy, 0 (0%) are recommending USNA as a Buy, 1 (50%) are recommending USNA as a Hold, 1 (50%) are recommending USNA as a Sell, and 0 (0%) are recommending USNA as a Strong Sell.

If you're new to stock investing, here's how to buy Usana Health Sciences stock.

What is USNA's earnings growth forecast for 2023-2023?

(NYSE: USNA) Usana Health Sciences's forecast annual earnings growth rate of 18.32% is forecast to beat the US Household & Personal Products industry's average forecast earnings growth rate of 9.57%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 26.86%.

Usana Health Sciences's earnings in 2023 is $69,350,000.

In 2023, USNA is forecast to generate $83,351,514 in earnings, with the lowest earnings forecast at $81,615,024 and the highest earnings forecast at $84,895,061.

What is USNA's revenue growth forecast for 2023-2025?

(NYSE: USNA) Usana Health Sciences's forecast annual revenue growth rate of 4.82% is forecast to beat the US Household & Personal Products industry's average forecast revenue growth rate of 3.01%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.33%.

Usana Health Sciences's revenue in 2023 is $998,601,000.On average, 1 Wall Street analysts forecast USNA's revenue for 2023 to be $20,081,540,746, with the lowest USNA revenue forecast at $20,081,540,746, and the highest USNA revenue forecast at $20,081,540,746. On average, 1 Wall Street analysts forecast USNA's revenue for 2024 to be $21,821,889,492, with the lowest USNA revenue forecast at $21,821,889,492, and the highest USNA revenue forecast at $21,821,889,492.

In 2025, USNA is forecast to generate $21,603,863,540 in revenue, with the lowest revenue forecast at $21,603,863,540 and the highest revenue forecast at $21,603,863,540.

What is USNA's forecast return on assets (ROA) for 2023-2025?

(NYSE: USNA) forecast ROA is N/A, which is lower than the forecast US Household & Personal Products industry average of 13.2%.

What is USNA's Price Target?

According to 2 Wall Street analysts that have issued a 1 year USNA price target, the average USNA price target is $52.75, with the highest USNA stock price forecast at $53.00 and the lowest USNA stock price forecast at $52.50.

On average, Wall Street analysts predict that Usana Health Sciences's share price could fall to $52.75 by Feb 13, 2024. The average Usana Health Sciences stock price prediction forecasts a potential downside of 14.03% from the current USNA share price of $61.36.

What is USNA's Earnings Per Share (EPS) forecast for 2023-2023?

(NYSE: USNA) Usana Health Sciences's current Earnings Per Share (EPS) is $3.60. In 2023, USNA's EPS is forecast to hit $4.32 (min: $4.23, max: $4.40).

What is USNA's forecast return on equity (ROE) for 2023-2025?

(NYSE: USNA) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.